Golimumab in the treatment of psoriatic arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2018.1524755
Abstract: ABSTRACT Introduction: Psoriatic arthritis (PsA) is an inflammatory arthritis that can be aggressive and destructive, resulting in significant morbidity. While many new agents have been approved for the treatment of PsA over the past decade,… read more here.
Keywords: psoriatic arthritis; psa; golimumab treatment; treatment ... See more keywords
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study.
Sign Up to like & getrecommendations! Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000025122
Abstract: ABSTRACT Golimumab is a fully human monoclonal antibody against tumor necrosis factor (TNF) approved for the treatment of ulcerative colitis and not for Crohn disease (CD). Many CD patients experience primary, secondary failure, or intolerance… read more here.
Keywords: golimumab treatment; treatment; spondyloarthritis; golimumab ... See more keywords
A review on golimumab in the treatment of psoriatic arthritis.
Sign Up to like & getrecommendations! Published in 2017 at "Immunotherapy"
DOI: 10.2217/imt-2017-0063
Abstract: Psoriatic arthritis (PsA) causes inflammation in and around the joints and usually affects people who already have psoriasis. However, some patients develop the joint problems before the psoriasis. Currently, there are five anti-TNF-α agents licensed… read more here.
Keywords: psoriatic arthritis; arthritis; review golimumab; golimumab treatment ... See more keywords